查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598441

香港腳治療市場：依類型、適應症、給藥途徑、銷售管道分類－2025-2030年全球預測

Tinea Pedis Treatment Market by Type (Antifungals, Drying Agents), Indication Type (Acute Ulcerative Tinea Pedis, Chronic Hyperkeratotic Tinea Pedis, Chronic Intertriginous Tinea Pedis), Route Of Administration, Sales Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年香港腳治療市場價值為14.9億美元，預計到2024年將達到15.7億美元，複合年成長率為6.20%，預計到2030年將達到22.8億美元。

香港腳，俗稱足癬腳，是一種影響腳部皮膚的廣泛真菌感染疾病。治療市場包括緩解症狀、預防復發和限制感染傳播所需的外用和口服抗真菌產品。治療用途包括非處方藥、處方藥和自然療法，最終用途是在藥房、醫院、專科診所等，服務於從運動員到免疫力較弱的患者等多種患者群體。市場參與企業的成長是由於人們對真菌感染疾病認知的提高、健身和運動參與的增加、更抗真菌藥物受到感染疾病的老年人口的增加，以及更高的功效和更少的副作用等因素推動的。的進步支持了這一點。機會包括開拓長效和速效製劑等新治療方法、滲透醫療需求未滿足的新興市場，以及整合遠端醫療以提供遠距離診斷和治療建議。然而，挑戰仍然存在，包括嚴格的監管核准、與抗真菌藥物相關的潛在副作用以及來自替代療法和家庭療法的競爭。原料成本波動以及長期使用可能產生抗藥性也帶來了限制。創新應著重於改進配方以提高患者用藥依從性、利用生物技術開發先進的抗真菌藥物以及研究微生物組在感染抵抗力中的作用。市場是動態的，消費者健康趨勢和技術進步相互作用，需要持續監控監管條件和患者的醫療偏好。透過與皮膚科醫生和醫療機構的夥伴關係，公司可以增強信譽和市場滲透力，最終確保符合國際健康標準，同時適應目標消費者的變化。

主要市場統計
基準年[2023] 14.9億美元
預測年份 [2024] 15.7億美元
預測年份 [2030] 22.8億美元
複合年成長率（%） 6.20%

市場動態：快速發展的香港腳治療市場的關鍵市場洞察

供需的動態交互作用正在改變香港腳治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 香港腳在人群中的盛行率很高
    • 人們對皮膚病的認知不斷提高
    • 各國非處方皮膚科產品的可用性
  • 市場限制因素
    • 與產品召回相關的重大問題
  • 市場機會
    • 香港腳新治療方案的出現
    • 遠端醫療和虛擬醫療保健的成長趨勢
  • 市場挑戰
    • 資金集中且耗時的核准流程

波特的五力：駕馭香港腳治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解香港腳治療市場的外部影響

外部宏觀環境因素在塑造香港腳治療市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解香港腳治療市場的競爭模式

香港腳治療市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣香港腳治療市場供應商的績效評估

FPNV 定位矩陣是評估香港腳治療市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製香港腳治療市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，香港腳治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中香港腳盛行率高
      • 人們對皮膚病的認知不斷提高
      • 每個經濟體都可以輕鬆獲得商業皮膚科產品。
    • 抑制因素
      • 與產品召回相關的嚴重問題
    • 機會
      • 香港腳新治療方法的出現
      • 遠端醫療和虛擬醫療保健的興起
    • 任務
      • 資金密集型且耗時的核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章香港腳治療市場：依類型

  • 抗真菌藥物
  • 乾燥劑

第7章依適應症類型分類的香港腳治療市場

  • 急性潰瘍性香港腳
  • 慢性角質化過度香港腳
  • 慢性間香港腳
  • 香港腳水痘

香港腳治療市場：依給藥途徑

  • 口服
  • 話題
    • 霜和乳液
    • 凝膠
    • 粉末
    • 噴

第9章香港腳治療市場：依銷售管道

  • 離線
    • 醫院/診所
    • 藥局
  • 線上

第10章美洲香港腳治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區香港腳治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲/中東/非洲香港腳治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Amneal Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • Enzon Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis AG
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.
Product Code: MRR-C002B1C996FC

The Tinea Pedis Treatment Market was valued at USD 1.49 billion in 2023, expected to reach USD 1.57 billion in 2024, and is projected to grow at a CAGR of 6.20%, to USD 2.28 billion by 2030.

Tinea Pedis, commonly known as athlete's foot, is a widespread fungal infection affecting the skin on the feet. The market for its treatment encompasses a range of antifungal products, both topical and oral, necessary for relieving symptoms, preventing recurrence, and inhibiting the spread of infection. Applications span across over-the-counter products, prescription treatments, and natural remedies, with end-use segments including pharmacies, hospitals, and specialty clinics, addressing a diverse patient base from athletes to individuals with compromised immunity. Market growth is propelled by factors such as increasing awareness of fungal infections, the rise in gym and sports participation, and the growing geriatric population susceptible to infections, matched with advancements in antifungal medications that offer better efficacy and reduced side effects. Opportunities lie in the development of novel treatments like long-acting and rapid-onset formulas, penetration into emerging markets with high unmet medical needs, and integration of telemedicine for remote diagnosis and treatment advice. However, challenges persist due to stringent regulatory approvals, potential side effects associated with antifungal drugs, and competition from alternative and home remedies. Limitations also arise from fluctuating raw material costs and the potential for drug resistance with prolonged use. Innovation should focus on enhancing drug formulations for increased patient adherence, leveraging biotechnology for advanced antifungal agents, and investigating the microbiome's role in infection resistance. The market is dynamic, driven by the interplay of consumer health trends and technological advancements, demanding continuous monitoring of regulatory landscapes and patient health care preferences. Businesses can leverage partnerships with dermatologists and health care organizations to bolster credibility and market penetration, ultimately catering to the evolving needs of target consumers while ensuring compliance with international health standards.

KEY MARKET STATISTICS
Base Year [2023] USD 1.49 billion
Estimated Year [2024] USD 1.57 billion
Forecast Year [2030] USD 2.28 billion
CAGR (%) 6.20%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tinea Pedis Treatment Market

The Tinea Pedis Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant prevalence of tinea pedis among population
    • Growing awareness about dermatological disorders
    • Easy availability of OTC dermatological products across economies
  • Market Restraints
    • Considerable issues associated with product recall
  • Market Opportunities
    • Emergence of new treatment options for tinea pedis
    • Rising trend of telemedicine and virtual healthcare
  • Market Challenges
    • Capital intensive and time consuming approval process

Porter's Five Forces: A Strategic Tool for Navigating the Tinea Pedis Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tinea Pedis Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tinea Pedis Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tinea Pedis Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tinea Pedis Treatment Market

A detailed market share analysis in the Tinea Pedis Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tinea Pedis Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tinea Pedis Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tinea Pedis Treatment Market

A strategic analysis of the Tinea Pedis Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tinea Pedis Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aetna Inc, Alva-Amco Pharmacal Companies, Inc, Amneal Pharmaceuticals Inc., Aurobindo Pharma Limited, Bausch Health Companies Inc., Bayer AG, Blueberry Therapeutics Ltd., Cipla Ltd., Creative Biolabs, Dr. Reddy's Laboratories Ltd., Enzon Pharmaceuticals, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Limited, Merck & Co., Inc., Mylan N.V., Novartis AG, Perrigo Company PLC, ProFoot, Inc., Sebela Pharmaceuticals Holdings Inc., Steris Healthcare PVT Ltd, Sun Pharmaceutical Industries Ltd., Taisho Pharmaceutical Co., Ltd., and Vibcare Pharma Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Tinea Pedis Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Antifungals and Drying Agents.
  • Based on Indication Type, market is studied across Acute Ulcerative Tinea Pedis, Chronic Hyperkeratotic Tinea Pedis, Chronic Intertriginous Tinea Pedis, and Vesiculobullous Tinea Pedis.
  • Based on Route Of Administration, market is studied across Oral and Topical. The Topical is further studied across Cream & Lotion, Gel, Powder, and Spray.
  • Based on Sales Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals & Clinics and Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant prevalence of tinea pedis among population
      • 5.1.1.2. Growing awareness about dermatological disorders
      • 5.1.1.3. Easy availability of OTC dermatological products across economies
    • 5.1.2. Restraints
      • 5.1.2.1. Considerable issues associated with product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of new treatment options for tinea pedis
      • 5.1.3.2. Rising trend of telemedicine and virtual healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive and time consuming approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tinea Pedis Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Antifungals
  • 6.3. Drying Agents

7. Tinea Pedis Treatment Market, by Indication Type

  • 7.1. Introduction
  • 7.2. Acute Ulcerative Tinea Pedis
  • 7.3. Chronic Hyperkeratotic Tinea Pedis
  • 7.4. Chronic Intertriginous Tinea Pedis
  • 7.5. Vesiculobullous Tinea Pedis

8. Tinea Pedis Treatment Market, by Route Of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Topical
    • 8.3.1. Cream & Lotion
    • 8.3.2. Gel
    • 8.3.3. Powder
    • 8.3.4. Spray

9. Tinea Pedis Treatment Market, by Sales Channel

  • 9.1. Introduction
  • 9.2. Offline
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Pharmacies
  • 9.3. Online

10. Americas Tinea Pedis Treatment Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Tinea Pedis Treatment Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Tinea Pedis Treatment Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Aetna Inc
  • 3. Alva-Amco Pharmacal Companies, Inc
  • 4. Amneal Pharmaceuticals Inc.
  • 5. Aurobindo Pharma Limited
  • 6. Bausch Health Companies Inc.
  • 7. Bayer AG
  • 8. Blueberry Therapeutics Ltd.
  • 9. Cipla Ltd.
  • 10. Creative Biolabs
  • 11. Dr. Reddy's Laboratories Ltd.
  • 12. Enzon Pharmaceuticals, Inc.
  • 13. GlaxoSmithKline PLC
  • 14. Glenmark Pharmaceuticals Limited
  • 15. Merck & Co., Inc.
  • 16. Mylan N.V.
  • 17. Novartis AG
  • 18. Perrigo Company PLC
  • 19. ProFoot, Inc.
  • 20. Sebela Pharmaceuticals Holdings Inc.
  • 21. Steris Healthcare PVT Ltd
  • 22. Sun Pharmaceutical Industries Ltd.
  • 23. Taisho Pharmaceutical Co., Ltd.
  • 24. Vibcare Pharma Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. TINEA PEDIS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. TINEA PEDIS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TINEA PEDIS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TINEA PEDIS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DRYING AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ACUTE ULCERATIVE TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CHRONIC HYPERKERATOTIC TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CHRONIC INTERTRIGINOUS TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY VESICULOBULLOUS TINEA PEDIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAM & LOTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY INDICATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 279. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 280. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023